Patent Application
20220306996
The present invention relates to biotechnology, and to electrochemical measurement of glucose utilizing a mutant glucose dehydrogenase.
For improvement of the thermal stability of proteins, a number of methods have been developed. Known examples of artificial approaches therefor include glycosylation, chemical cross-linking and binding to polymers. These methods are widely applicable to arbitrary target proteins since the methods comprehensively protect the target proteins to achieve stabilization of the proteins. However, in cases of enzymes, these methods have a non-negligible effect on the activity of the enzyme, low-reproducibility of the results, leading to practical problems such as requirement of an additional step for purification and modification.
U.S. Pat. Nos. 9,074,239, and 8,945,359 disclose techniques for improvement of the thermal stability of FAD-dependent glucose dehydrogenase (FAD-GDH) by site-directed mutagenesis. However, those documents do not suggest stabilization of binding between subunits in relation to mutagenesis in a catalytic subunit. U.S. Pat. No. 8,945,359 describes that the specific activity of the mutant at 50° C. is only 50% relative to the specific activity at 30° C., and that the mutant is deactivated at a high temperature condition of 60° C.
Biotechnol Lett 1774-8 (2015) reports that a mutant enzyme containing cysteine residues introduced at two specific sites of a catalytic subunit showed improved thermal resistance while maintaining the activity and specificity.
Glucose dehydrogenase is an enzyme often used for glucose sensors.
Glucose sensors for daily use in self-blood glucose measurement by diabetic patients are required to show accurate measured values in any situation or environment. Therefore, the enzyme, which is a key factor of the performance, is required to have high stability so as to avoid heat inactivation.
Based on information on the crystal structure of FAD-GDH, which is a heterotrimer comprising an electron transfer subunit, the present inventors introduced cysteine residues to specific sites on an intersubunit interface to form a disulfide bond on the interface, to thereby succeed in stabilization of the higher-order structure of the heterotrimer and remarkable improvement of the thermal resistance. Further, since the electron transfer activity of the mutant enzyme could be remarkably increased by introduction of cysteine residues to positions which are thought to be in the intramolecular electron transfer pathway of the enzyme, the present inventors found that the cysteine residues play an important role not only in cross-linking between the subunits, but also in assisting the electron transfer.
In one mode of the present invention, a mutant glucose dehydrogenase having improved thermal stability is provided without deterioration of the enzyme activity.
According to one aspect of the present invention, a mutant FAD-dependent glucose dehydrogenase comprising:
a catalytic subunit;
an electron transfer subunit; and
a hitchhiker subunit;
wherein each of the amino acid sequence of the catalytic subunit and the amino acid sequence of the electron transfer subunit contains a cysteine residue introduced therein, the catalytic subunit and the electron transfer subunit being bound to each other through a disulfide bond between the cysteine residues, is provided.
According to another aspect of the present invention, the mutant FAD-dependent glucose dehydrogenase in which the amino acid sequence of the electron transfer subunit comprises another cysteine residue introduced therein, and in which the amino acid sequence of the hitchhiker subunit comprises a cysteine residue introduced therein, the hitchhiker subunit and the electron transfer subunit being bound to each other through a disulfide bond between the cysteine residues, is provided.
According to another aspect of the present invention, the mutant FAD-dependent glucose dehydrogenase in which the amino acid sequence of the catalytic subunit and the amino acid sequence of the electron transfer subunit contains a cysteine residue introduced therein, the catalytic subunit and the electron transfer subunit being bound to each other through a disulfide bond between the cysteine residues, and simultaneously, the amino acid sequence of the electron transfer subunit comprises another cysteine residue introduced therein, and in which the amino acid sequence of the hitchhiker subunit comprises a cysteine residue introduced therein, the hitchhiker subunit and the electron transfer subunit being bound to each other through a disulfide bond between the cysteine residues, is provided.
According to another aspect of the present invention, an enzyme electrode comprising the mutant FAD-dependent glucose dehydrogenase is provided.
According to another aspect of the present invention, a biosensor comprising the enzyme electrode is provided.
The glucose dehydrogenase according to one embodiment of the present invention is an FAD-dependent glucose dehydrogenase comprising:
a catalytic subunit (α subunit);
an electron transfer subunit (β subunit); and
a hitchhiker subunit (γ subunit);
wherein each of at least the catalytic subunit and the electron transfer subunit comprises a cysteine residue introduced therein, the cysteine residues forming a disulfide bond therebetween.
The glucose dehydrogenase is hereinafter also referred to as mutant glucose dehydrogenase (GDH) or mutant FAD-GDH.
Thus, the mutant glucose dehydrogenase is a trimer composed of three subunits. The subunits may be linked to each other through a linker(s) and/or the like.
Known examples of an FAD-GDH which is a trimer composed of the three subunits include those of Burkholderia cepacia, Burkholderia cenocepacia, Burkholderia thailandensis, Ralstonia pickettii, Ralstonia solanacearum, Burkholderia phytofirmans, Ralstonia sp., Moraxellaceae bacterium, Pseudomonas knackmussii, Yersinia nurmii, Edaphovirga cremea, Silvimonas terrae, Zymobacter palmae, Cobetia sp., Halomonas sp. and Ewingella americana The mutant FAD-GDH according to one embodiment of the present invention can be obtained by introducing mutations thereto.
According to one embodiment of the present invention, in the mutant FAD-GDH, each of the amino acid sequence of the catalytic subunit and the amino acid sequence of the electron transfer subunit comprises a cysteine residue introduced therein, the catalytic subunit and the electron transfer subunit being bound to each other through a disulfide bond between the cysteine residues. The introduction of a cysteine residue includes introduction by amino acid substitution and introduction by insertion.
Each subunit is described below using the FAD-GDH of Burkholderia cepacia as an example. However, the mutant GDH is not limited to the following embodiments.
The Burkholderia cepacia is not limited. For example, the Burkholderia cepacia KS1 strain may be used. The Burkholderia cepacia KS1 strain has been deposited with International Patent Organism Depositary, National Institute of Advanced Industrial Science and Technology (currently International Patent Organism Depositary (IPOD), National Institute of Technology and Evaluation (NITE)) as of Sep. 25, 2000 under the accession number FERM BP-7306.
The catalytic subunit, also called α subunit, is a polypeptide having a catalytic activity of glucose dehydrogenation dependently on FAD (flavin adenine dinucleotide). The catalytic subunit preferably contains an Fe—S cluster.
SEQ ID NO:3 is an amino acid sequence of the FAD-GDH catalytic subunit of the Burkholderia cepacia KS1 strain. The following description is given with reference to this sequence.
The cysteine introduction site in the amino acid sequence of the catalytic subunit is preferably in a region forming the interface with the electron transfer subunit in the spatial structure of the FAD-GDH. For example, cysteine is introduced to a position in the region of amino acid positions 200 to 240 of SEQ ID NO:3. Thus, an amino acid residue in the region of amino acid positions 200 to 240 of SEQ ID NO:3 is substituted with cysteine. This region in the catalytic subunit is a region located on the interface with the electron transfer subunit in the spatial structure of GDH.
Specific examples of the amino acid in this region include the proline residue at position 205, glycine residue at position 208, asparagine residue at position 215, isoleucine residue at position 224, and glutamic acid residue at position 235 in the amino acid sequence of SEQ ID NO:3. Introduction of cysteine residue includes substitution by cysteine and insertion of cysteine. For example, any of the above-described amino acid residues may be substituted with a cysteine residue. Alternatively, when a cysteine residue is inserted, the cysteine residue may be inserted at a position immediately before or immediately after these residues.
The above-described positions of amino acid substitution are positions in SEQ ID NO:3. However, the amino acid sequence of the catalytic subunit to which the mutation is to be introduced may have a length different from the length of SEQ ID NO:3. For example, in cases where the amino acid sequence of the catalytic subunit to which the mutation is to be introduced is shorter by three amino acids in the N-terminal side compared to SEQ ID NO:3, the proline residue at position 205 of SEQ ID NO:3 corresponds to the proline at position 202 of the amino acid sequence. Such a case is also regarded as substitution of the proline residue corresponding to the “proline residue at position 205”, and included in a mode of the present invention. The same applies to other residues.
Among the above-described residues, the proline residue at position 205 is preferably substituted by a cysteine residue. This proline residue exists in the amino acid motif “ARNSRPYD” (SEQ ID NO: 23). In one embodiment, a cysteine residue is introduced to substitute the proline residue in this motif, and thereby the catalytic subunit of the mutant glucose dehydrogenase such as one having an amino acid sequence at least 60, 70, 80, 90, or 95% identical to the amino acid sequence of SEQ ID NO:3, 7, 13, 17 or 21 comprises the amino acid sequence of “ARNSRCYD” (SEQ ID NO: 24).
FAD-GDH is also known in other microorganisms. In the amino acid sequence of their catalytic subunit, for example, in an amino acid sequence having an identity of at least 60%, at least 80%, at least 90%, or at least 95% to SEQ ID NO:3, cysteine may be introduced into the region described above, or to the position of the amino acid residue corresponding to the specific amino acid residue described above.
More specifically, the amino acid sequence of the catalytic subunit to which the mutation is to be introduced may be aligned with the amino acid sequence of SEQ ID NO:3, and an amino acid residue in the region of amino acid positions 200 to 240 of SEQ ID NO:3, for example, the amino acid whose position corresponds to the position of the proline residue at position 205, glycine residue at position 208, asparagine residue at position 215, isoleucine residue at position 224, or glutamic acid residue at position 235, may be substituted with cysteine.
Any polypeptide having some degree of a sequence identity to SEQ ID NO:3 or the other sequence of the catalytic subunit described below can be used to prepare a catalytic subunit of the mutant glucose dehydrogenase as long as it maintains the function of the catalytic subunit, i.e. forming a complex with the electron transfer subunit and the hitchhiker subunit and exhibiting glucose dehydrogenase activity.
Examples of the amino acid sequence of the GDH α subunit having an identity of not less than 60% to SEQ ID NO:3 include the sequence of the α subunit of each of the followings: Burkholderia cenocepacia J2315 strain (GenBank Accession No. WP 006482972), Burkholderia thailandensis TXDOH strain (WP_009900298), Ralstonia pickettii 12D strain (WP_012761508), Ralstonia solanacearum IPO1609 strain (WP_003265143), Burkholderia phytofirmans PsJN strain (WP_012428610), Ralstonia sp. (WP_048931828), Moraxellaceae bacterium (WP_114899537), Pseudomonas knackmussii (WP_043248521), Yersinia nurmii (WP_049596850), Edaphovirga cremea (WP_114193339), Silvimonas terrae (WP_184102398), Zymobacter palmae (WP_027705356), Cobetia sp. (WP_158773851), Halomonas sp. (WP_107334716) and Ewingella americana (WP_034788281).
As described above, the region and residues to which the cysteine residue is introduced in these catalytic subunits can be determined by aligning the sequence of each catalytic subunit with that of B. cepacia (SEQ ID NO: 3).
For example, in the case of the catalytic subunit of E. americana GDH (SEQ ID NO: 7), as shown in
Another embodiment of the catalytic subunit includes a catalytic subunit comprising an amino acid sequence having at least 60%, 80%, 90% or 95% identity to SEQ ID NO: 7 wherein cysteine is introduced at the position corresponding to the proline residue at position 202, glycine residue at position 205, asparagine residue at position 212, isoleucine residue at position 221, or glutamic acid residue at position 232 in SEQ ID NO: 7.
For example, in the case of the catalytic subunit of Silvimonas terrae GDH (SEQ ID NO: 13), as shown in
Another embodiment of the catalytic subunit includes a catalytic subunit comprising an amino acid sequence having at least 60%, 80%, 90% or 95% identity to SEQ ID NO: 13 wherein cysteine is introduced at the position corresponding to the proline residue at position 204 in SEQ ID NO: 13.
For example, in the case of the catalytic subunit of Zymobacter palmae GDH (SEQ ID NO: 17), as shown in
Another embodiment of the catalytic subunit includes a catalytic subunit comprising an amino acid sequence having at least 60%, 80%, 90% or 95% identity to SEQ ID NO: 17 wherein cysteine is introduced at the position corresponding to the proline residue at position 200 in SEQ ID NO: 17.
For example, in the case of the catalytic subunit of Cobetia sp. GDH (SEQ ID NO: 21), the proline residue at position 205 corresponds to the proline residue at position 204 in SEQ ID NO: 21.
Another embodiment of the catalytic subunit includes a catalytic subunit comprising an amino acid sequence having at least 60%, 80%, 90% or 95% identity to SEQ ID NO: 21 wherein cysteine is introduced at the position corresponding to the proline residue at position 204 in SEQ ID NO: 21.
The amino acid sequence of the catalytic subunit (α subunit) may contain not only the mutation that introduces cysteine, but also an additional mutation. Known examples of mutants comprising mutations in the catalytic subunit of FAD-dependent GDH derived from Burkholderia cepacia include a mutant in which the amino acid residues at positions 472 and 475 are substituted (WO 2005/103248), a mutant in which the amino acid residues at positions 326, 365, and 472 are substituted (QYY mutant JP 2012-090563 A), a mutant in which position 365 and position(s) 326, 472, 475, 529, and/or the like are substituted (WO 2006/137283). The catalytic subunit of the mutant GDH according to one embodiment of the present invention may have these mutations.
The electron transfer subunit is also called β subunit, and contains at least one heme-binding domain. The subunit has a function to transfer electrons generated by reaction using glucose as a substrate, to an electrode.
The electron transfer subunit comprises a cysteine residue introduced therein, and this cysteine residue forms a disulfide bond with the cysteine residue introduced to the catalytic subunit.
The electron transfer subunit is not limited as long as it has a function to transfer electrons generated by glucose dehydrogenation to an electrode. Electron transfer subunits derived from various organisms, including known electron transfer subunits, may be used. The electron transfer subunit may be derived from the same microorganism as the microorganism from which the catalytic subunit is derived. Examples of the electron transfer subunit include the electron transfer subunit of GDH of Burkholderia cepacia. Examples of the GDH electron transfer subunit of the B. cepacia KS1 strain include a polypeptide comprising the amino acid sequence of SEQ ID NO:4. SEQ ID NO:4 is an amino acid sequence of the GDH β subunit of the Burkholderia cepacia KS1 strain. The following description is given with reference to this sequence.
The cysteine introduction site in the amino acid sequence of the electron transfer subunit is preferably in a region forming the interface with the catalytic subunit. For example, cystein is introduced to a position in the region of amino acid positions 330 to 400 of the amino acid sequence of SEQ ID NO:4. Thus, an amino acid residue in the region of amino acid positions 330 to 400 of SEQ ID NO:4 is substituted with cysteine. This region in the electron transfer subunit is a region located on the interface with the catalytic subunit in the spatial structure of GDH.
More specific examples of the amino acid in this region include the threonine residue at position 336, glycine residue at position 385, aspartic acid residue at position 383, and tyrosine residue at position 391 in the amino acid sequence of SEQ ID NO:4. Any of these may be substituted with a cysteine residue. When a cysteine residue is inserted, the cysteine residue may be inserted at a position immediately before or immediately after these residues.
Among the above-described residues, the aspartic acid residue at position 383 is preferably substituted by a cysteine residue. This amino acid residue exists at a position three amino acids before the amino acid motif “MP(A/G)F” (SEQ ID NO: 25). In one embodiment, a cysteine residue is introduced to substitute the amino acid residue three amino acid before this motif, and thereby the electron transfer subunit of the mutant glucose dehydrogenase such as one having an amino acid sequence at least 60, 70, 80, 90, or 95% identical to the amino acid sequence of SEQ ID NO: 4, 8, 14, 18 or 22 comprises the amino acid sequence of “CXXMP(A/G)F” (SEQ ID NO: 26).
Examples of a preferred combination of the cysteine introduction site in the region in the catalytic subunit (the region of amino acid positions 200 to 240 of SEQ ID NO:3) and the cysteine introduction site in the region in the electron transfer subunit (the region of amino acid positions 330 to 400 of SEQ ID NO:4) include the combination of the proline at position 205 of the catalytic subunit and the aspartic acid at position 383 of the electron transfer subunit, and the combination of the asparagine at position 215 of the catalytic subunit and the threonine at position 336 of electron transfer subunit. These combinations of residues are combinations of residues having a distance of about 5 Å from each other in the spatial structure of FAD-GDH, and capable of more efficient formation of a disulfide bond.
The mutant glucose dehydrogenase may also be a mutant glucose dehydrogenase in which the amino acid sequence of the electron transfer subunit contains another cysteine residue introduced, which cysteine residue forms a disulfide bond with a cysteine residue introduced in the amino acid sequence of the hitchhiker subunit, to bind the hitchhiker subunit and the electron transfer subunit to each other.
The another cysteine residue is preferably introduced into a region of the electron transfer subunit which is on the interface with the hitchhiker subunit. Examples of such a region include the region of amino acid positions 341 to 350 in the amino acid sequence of SEQ ID NO:4. Thus, an amino acid residue in the region of amino acid positions 341 to 350 of SEQ ID NO:4 may be substituted with cysteine. This region in the electron transfer subunit is a region located on the interface with the hitchhiker subunit in the spatial structure of GDH.
More specific examples of the amino acid in this region include the threonine residue at position 345, proline residue at position 346, and tyrosine residue at position 349 in the amino acid sequence of the region of SEQ ID NO:4. Introduction of cysteine residue includes substitution by cysteine and insertion of cysteine. For example, any of the above-described amino acid residues may be substituted with a cysteine residue. Alternatively, when a cysteine residue is inserted, the cysteine residue may be inserted at a position immediately before or immediately after these residues.
Among the above-described residues, the tyrosine residue at position 349 is preferably substituted by a cysteine residue. This amino acid residue exists at a position one amino acid before the amino acid motif “YPS(L/M)” (SEQ ID NO: 27). In one embodiment, a cysteine residue is introduced to substitute the amino acid residue one amino acid before this motif, and thereby the electron transfer subunit of the mutant glucose dehydrogenase such as one having an amino acid sequence at least 60, 70, 80, 90, or 95% identical to the amino acid sequence of SEQ ID NO: 4, 8, 14, 18 or 22 comprises the amino acid sequence of “CYPS(L/M)” (SEQ ID NO: 28).
The above-described positions of amino acid substitution mutation are positions in SEQ ID NO:4. However, the amino acid sequence of the electron transfer subunit to which the mutation is to be introduced may have a length different from the length of SEQ ID NO:4. For example, in cases where the amino acid sequence of the electron transfer subunit to which the mutation is to be introduced is shorter by five amino acids in the N-terminal side compared to SEQ ID NO:4, the threonine residue at position 336 of SEQ ID NO:4 corresponds to the threonine at position 331 of the amino acid sequence. Such a case is also regarded as substitution of the threonine residue corresponding to the “threonine residue at position 336”, and included in a mode of the present invention. The same applies to other residues.
The electron transfer subunit may also comprise another mutation in addition to the mutation that introduces cysteine.
The electron transfer subunit contains three heme-binding domains. The electron transfer subunit may be a mutant (truncated) electron transfer subunit in which the first heme-binding domain and the second heme-binding domain, that is, the first and second domains as counted from the N-terminal side, respectively, are deleted. Such a mutant electron transfer subunit is disclosed in US 2019-0010215.
Thus, in the electron transfer subunit having three heme-binding domains (CXXCH (SEQ ID NO: 31) motifs), the first and second heme-binding domains as counted from the N-terminal side, or a region(s) including these, may be deleted. The following description uses the electron transfer subunit of Burkholderia cepacia as a representative example. In SEQ ID NO:4, there are the first heme-binding domain (amino acid positions 43 to 47), second heme-binding domain (amino acid positions 191 to 195), and third heme-binding domain (amino acid positions 334 to 338). Among these, the first heme-binding domain and second heme-binding domain may be deleted, or the region including the first and second heme-binding domains (amino acid positions 43 to 195) may be deleted.
Examples of a mutant electron transfer subunit in which the region including the first and second heme-binding domains is deleted include a mutant electron transfer subunit composed of amino acid positions 314 to 425 or 330 to 425 of SEQ ID NO:4.
GDH is known also in other microorganisms. In the amino acid sequence of their electron transfer subunit, for example, in an amino acid sequence having an identity of at least 60%, at least 80%, at least 90%, or at least 95% to SEQ ID NO:4 or to the truncated sequence composed of amino acid positions 314 to 425 or 330 to 425 of SEQ ID NO:4, cysteine may be introduced to a position corresponding to such an amino acid residue as the threonine residue at position 336, glycine residue at position 385, aspartic acid residue at position 383, or tyrosine residue at position 391, and/or the threonine residue at position 345, proline residue at position 346, or tyrosine residue at position 349.
Specifically, the amino acid sequence of the electron transfer subunit to which the mutation is to be introduced may be aligned with the amino acid sequence of SEQ ID NO:4, and the amino acid whose position corresponds to the position of the threonine residue at position 336, glycine residue at position 385 aspartic acid residue at position 383, or tyrosine residue at position 391; or the threonine residue at position 345, proline residue at position 346, or tyrosine residue at position 349; of SEQ ID NO:4 may be substituted with cysteine.
Any polypeptide having some degree of a sequence identity to SEQ ID NO:4 or the other sequence of the electron transfer subunit described below can be used to prepare an electron transfer subunit of the mutant glucose dehydrogenase as long as it maintains the function of the electron transfer subunit, i.e. forming a complex with the catalytic subunit and the hitchhiker subunit and receiving and transferring an electron. An amino acid sequence of an electron transfer subunit preferably maintains three heme-binding domains or in the case of a truncated form, the third three heme-binding domain.
Examples of the amino acid sequence of the GDH electron transfer subunit having an identity of at least 60% to SEQ ID NO:4 include the sequence of the electron transfer subunit of each of the following: Burkholderia cenocepacia J2315 strain (WP_006482958), Burkholderia thailandensis TXDOH strain (WP_009900297), Ralstonia pickettii 12D strain (WP_012761509), Ralstonia solanacearum IPO1609 strain (WP_049281214), Burkholderia phytofirmans PsJN strain (WP_012428609), Ralstonia sp. (WP_048931829), Moraxellaceae bacterium (WP_114899536), Pseudomonas knackmussii (WP_043248520), Yersinia nurmii (WP_049596851), Edaphovirga cremea (WP_114193338), Silvimonas terrae (WP_184102397), Zymobacter palmae (WP_211245188), Cobetia sp. (WP_158773850), Halomonas sp. (WP_107336529) and Ewingella americana (WP_034788317).
As described above, the region and residues to which the cysteine residue is introduced in these electron transfer subunits can be determined by aligning the sequence of each electron transfer subunit with that of B. cepacia (SEQ ID NO: 4).
For example, in the case of the electron transfer subunit of E. americana (SEQ ID NO: 8), as shown in
Furthermore, in the case of the electron transfer subunit of E. americana (SEQ ID NO: 8), as shown in
In SEQ ID NO: 8, there are the first heme-binding domain (amino acid positions 41 to 45), second heme-binding domain (amino acid positions 187 to 191), and third heme-binding domain (amino acid positions 326 to 330). Among these, the first heme-binding domain and second heme-binding domain may be deleted, or the region including the first and second heme-binding domains (amino acid positions 41 to 191) may be deleted. Examples of a mutant electron transfer subunit in which the region including the first and second heme-binding domains is deleted include a mutant electron transfer subunit composed of amino acid positions 306 to 420 or 322 to 420 of SEQ ID NO: 8.
Another embodiment of the electron transfer subunit includes an electron transfer subunit comprising an amino acid sequence having at least 60%, 80%, 90% or 95% identity to SEQ ID NO: 8 or amino acids 306 to 420 of SEQ ID NO: 8 wherein a first cysteine is introduced at the position corresponding to the serine residue at position 328, glutamic acid residue at position 375, phenylalanine residue at position 377, or aspartic acid residue at position 383, and/or a second cysteine is introduced at the position corresponding to the serine residue at position 337, glutamine residue at position 338, and tyrosine residue at position 341 in SEQ ID NO: 8.
Furthermore, in the case of the electron transfer subunit of Silvimonas terrae (SEQ ID NO: 14), as shown in
In SEQ ID NO: 14, there are the first heme-binding domain (amino acid positions 43 to 47), second heme-binding domain (amino acid positions 191 to 195), and third heme-binding domain (amino acid positions 332 to 336). Among these, the first heme-binding domain and second heme-binding domain may be deleted, or the region including the first and second heme-binding domains (amino acid positions 43 to 195) may be deleted. Examples of a mutant electron transfer subunit in which the region including the first and second heme-binding domains is deleted include a mutant electron transfer subunit composed of amino acid positions 332 to 481 of SEQ ID NO: 14.
Another embodiment of the electron transfer subunit includes an electron transfer subunit comprising an amino acid sequence having at least 60%, 80%, 90% or 95% identity to SEQ ID NO: 14 or amino acids 332 to 481 of SEQ ID NO: 14 wherein a first cysteine is introduced at the position corresponding to the histidine residue at position 382 in SEQ ID NO: 14 and/or a second cysteine is introduced at the position corresponding to the alanine residue at position 347 in SEQ ID NO: 14.
Furthermore, in the case of the electron transfer subunit of Zymobacter palmae (SEQ ID NO: 18), as shown in
In SEQ ID NO: 18, there are the first heme-binding domain (amino acid positions 49 to 53), second heme-binding domain (amino acid positions 196 to 200), and third heme-binding domain (amino acid positions 340 to 344). Among these, the first heme-binding domain and second heme-binding domain may be deleted, or the region including the first and second heme-binding domains (amino acid positions 49 to 200) may be deleted. Examples of a mutant electron transfer subunit in which the region including the first and second heme-binding domains is deleted include a mutant electron transfer subunit composed of amino acid positions 340 to 433 of SEQ ID NO: 18.
Another embodiment of the electron transfer subunit includes an electron transfer subunit comprising an amino acid sequence having at least 60%, 80%, 90% or 95% identity to SEQ ID NO: 18 or amino acids 340 to 433 of SEQ ID NO: 18 wherein a first cysteine is introduced at the position corresponding to the aspartic acid residue at position 389 in SEQ ID NO: 18 and/or a second cysteine is introduced at the position corresponding to the tyrosine residue at position 355 in SEQ ID NO: 18.
Furthermore, in the case of the electron transfer subunit of Cobetia sp. (SEQ ID NO: 22), as shown in
In SEQ ID NO: 22, there are the first heme-binding domain (amino acid positions 84 to 88), second heme-binding domain (amino acid positions 231 to 235), and third heme-binding domain (amino acid positions 418 to 422). Among these, the first heme-binding domain and second heme-binding domain may be deleted, or the region including the first and second heme-binding domains (amino acid positions 84 to 235) may be deleted. Examples of a mutant electron transfer subunit in which the region including the first and second heme-binding domains is deleted include a mutant electron transfer subunit composed of amino acid positions 418 to 522 of SEQ ID NO: 22.
Another embodiment of the electron transfer subunit includes an electron transfer subunit comprising an amino acid sequence having at least 60%, 80%, 90% or 95% identity to SEQ ID NO: 22 or amino acids 418 to 522 of SEQ ID NO: 22 wherein a first cysteine is introduced at the position corresponding to the seine residue at position 467 in SEQ ID NO: 22 and/or a second cysteine is introduced at the position corresponding to the tyrosine residue at position 433 in SEQ ID NO: 22.
The glucose dehydrogenase also includes a hitchhiker subunit. The hitchhiker subunit is also called γ subunit, and has a function of forming a complex with the α subunit and β subunit, and being secreted into periplasm. The hitchhiker subunit is not limited as long as it has the function. γ subunits derived from various organisms, including known γ subunits, may be used. The hitchhiker subunit may be derived from the same microorganism as the microorganism from which the catalytic subunit or electron transfer subunit is derived. Examples of the hitchhiker subunit include the hitchhiker subunit of GDH of Burkholderia cepacia.
SEQ ID NO:2 is an amino acid sequence of the GDH hitchhiker subunit of the Burkholderia cepacia KS1 strain. The following description is given with reference to this sequence.
As described above, the hitchhiker subunit may contain a cysteine residue introduced therein for formation of a disulfide bond with the electron transfer subunit.
The cysteine introduction site in the amino acid sequence of the hitchhiker subunit is preferably in a region forming the interface with the electron transfer subunit. For example, cysteine is introduced to a position in the region of amino acid positions 140 to 160 in the amino acid sequence of SEQ ID NO:2. Thus, an amino acid residue in the region of amino acid positions 140 to 160 of SEQ ID NO:2 is substituted with cysteine. This region in the hitchhiker subunit is a region located on the interface with the electron transfer subunit in the spatial structure of GDH.
Specific examples of the amino acid in this region include the threonine residue at position 145, asparagine residue at position 154, and lysine residue at position 155 in the amino acid sequence of SEQ ID NO:2. Introduction of cysteine residue includes substitution by cysteine and insertion of cysteine. For example, any of the above-described amino acid residues may be substituted with a cysteine residue. Alternatively, when a cysteine residue is inserted, the cysteine residue may be inserted at a position immediately before or immediately after these residues.
Among the above-described residues, the lysine residue at position 155 is preferably substituted by a cysteine residue. This amino acid residue exists at a position one amino acid before the amino acid motif “PXXWXXXP” (SEQ ID NO: 29). In one embodiment, a cysteine residue is introduced to substitute the amino acid residue one amino acid before this motif, and thereby the hitchhiker subunit of the mutant glucose dehydrogenase such as one having an amino acid sequence at least 60, 70, 80, 90, or 95% identical to the amino acid sequence of SEQ ID NO:2, 6, 12, 16 or 20 comprises the amino acid sequence of “CPXXWXXXP” (SEQ ID NO: 30).
The above-described positions of amino acid substitution mutation are positions in SEQ ID NO:2. However, the amino acid sequence of the hitchhiker subunit to which the mutation is to be introduced may have a length different from the length of SEQ ID NO:2. For example, in cases where the amino acid sequence of the hitchhiker subunit to which the mutation is to be introduced is longer by two amino acids in the N-terminal side compared to SEQ ID NO:2, the threonine residue at position 145 of SEQ ID NO:2 corresponds to the threonine at position 147 of the amino acid sequence. Such a case is also regarded as substitution of the threonine residue corresponding to the “threonine residue at position 145”, and included in a mode of the present invention. The same applies to other residues.
Examples of a preferred combination of the cysteine introduction site for disulfide formation with the hitchhiker subunit in the electron transfer subunit (the region of amino acid positions 341 to 350 of SEQ ID NO:4) and the cysteine introduction site in the hitchhiker subunit (the region of amino acid positions 140 to 160 of SEQ ID NO:2) include the combination of the threonine at position 345 of the electron transfer subunit and the asparagine at position 154 of the hitchhiker subunit, and the combination of the tyrosine at position 349 of the electron transfer subunit and the lysine at position 155 of the hitchhiker subunit. These combinations of residues are combinations of residues having a distance of about 5 Å from each other in the spatial structure of FAD-GDH, and capable of more efficient formation of a disulfide bond.
The hitchhiker subunit may also comprise another mutation in addition to the mutation that introduces cysteine.
GDH is known also in other microorganisms. In the amino acid sequence of their hitchhiker subunit, for example, in an amino acid sequence having an identity of at least 60%, at least 80%, at least 90%, or at least 95% to SEQ ID NO:2, cysteine may be introduced into the region described above, or to the position of the amino acid residue corresponding to the specific amino acid residue described above.
Specifically, the amino acid sequence of the hitchhiker subunit to which the mutation is to be introduced may be aligned with the amino acid sequence of SEQ ID NO:2, and the amino acid whose position corresponds to the position of the threonine residue at position 145, asparagine residue at position 154, or lysine residue at position 155 of SEQ ID NO:2 may be substituted with cysteine.
Any polypeptide having some degree of a sequence identity to SEQ ID NO:2 or the other sequence of the hitchhiker subunit described below can be used to prepare a hitchhiker subunit of the mutant glucose dehydrogenase as long as it maintains the function of the hitchhiker subunit, i.e. forming a complex with the catalytic subunit and the electron transfer subunit and being secreted into periplasm.
Examples of the amino acid sequence of the GDH hitchhiker subunit having an identity of at least 60% to SEQ ID NO:2 include the sequence of the γ subunit of each of the following: Burkholderia cenocepacia J2315 strain (WP_006482974), Burkholderia thailandensis TXDOH strain (WP_009900299), Ralstonia pickettii 12D strain (WP_012761507), Ralstonia solanacearum IPO1609 strain (WP_003265142), Burkholderia phytofirmans PsJN strain (WP_012428611), Ralstonia sp. (WP_048931990), Moraxellaceae bacterium (WP_114899538), Pseudomonas knackmussii (WP_043248523), Yersinia nurmii (WP_049596849), Edaphovirga cremea (WP_114193340), Silvimonas terrae (WP_184102399), Zymobacter palmae (BBG29837), Cobetia sp. (WP_158773852), Halomonas sp. (WP_107334715) and Ewingella americana (WP_034788279).
As described above, the region and residues to which the cysteine residue is introduced in these hitchhiker subunits can be determined by aligning the sequence of each hitchhiker subunit with that of B. cepacia (SEQ ID NO: 2).
For example, in the case of the hitchhiker subunit of E. americana (SEQ ID NO: 6), as shown in
Another embodiment of the hitchhiker subunit includes a hitchhiker subunit comprising an amino acid sequence having at least 60%, 80%, 90% or 95% identity to SEQ ID NO: 6 wherein cysteine is introduced at the position corresponding to the valine residue at position 147, asparagine residue at position 156, or arginine residue at position 157 in SEQ ID NO: 6.
For example, in the case of the hitchhiker subunit of Silvimonas terrae (SEQ ID NO: 12), as shown in
Another embodiment of the hitchhiker subunit includes a hitchhiker subunit comprising an amino acid sequence having at least 60%, 80%, 90% or 95% identity to SEQ ID NO: 12 wherein cysteine is introduced at the position corresponding to the alanine residue at position 168 in SEQ ID NO: 12.
For example, in the case of the hitchhiker subunit of Zymobacter palmae (SEQ ID NO: 16), as shown in
Another embodiment of the hitchhiker subunit includes a hitchhiker subunit comprising an amino acid sequence having at least 60%, 80%, 90% or 95% identity to SEQ ID NO: 16 or amino acids 19 to 195 of SEQ ID NO: 16 wherein cysteine is introduced at the position corresponding to the arginine residue at position 182 in SEQ ID NO: 16.
For example, in the case of the hitchhiker subunit of Cobetia sp. (SEQ ID NO: 20), as shown in
Another embodiment of the hitchhiker subunit includes a hitchhiker subunit comprising an amino acid sequence having at least 60%, 80%, 90% or 95% identity to SEQ ID NO: 20 or amino acids 14 to 207 of SEQ ID NO: 20 wherein cysteine is introduced at the position corresponding to the glutamine residue at position 198 in SEQ ID NO: 20.
In one embodiment of a mutant FAD-dependent glucose dehydrogenase,
the catalytic subunit comprises an amino acid sequence having at least 60%, 70%, 80%, 90% or 95% identity to SEQ ID NO: 3 wherein cysteine is introduced at the position corresponding to the proline residue at position 205 in SEQ ID NO: 3,
the electron transfer subunit comprises an amino acid sequence having at least 60%, 70%, 80%, 90% or 95% identity to SEQ ID NO: 4 or amino acids 330 to 425 of SEQ ID NO: 4 wherein a first cysteine is introduced at the position corresponding to the aspartic acid residue at position 383 in SEQ ID NO: 4 and a second cysteine is introduced at the position corresponding to the threonine residue at position 345 in SEQ ID NO: 4, and
the hitchhiker subunit comprises an amino acid sequence having at least 60%, 70%, 80%, 90% or 95% identity to SEQ ID NO: 2 wherein cysteine is introduced at the position corresponding to the asparagine residue at position 154 in SEQ ID NO: 2.
In one embodiment of a mutant FAD-dependent glucose dehydrogenase,
the catalytic subunit comprises an amino acid sequence having at least 60%, 70%, 80%, 90% or 95% identity to SEQ ID NO: 3 wherein cysteine is introduced at the position corresponding to the proline residue at position 205 in SEQ ID NO: 3,
the electron transfer subunit comprises an amino acid sequence having at least 60%, 70%, 80%, 90% or 95% identity to SEQ ID NO: 4 or amino acids 330 to 425 of SEQ ID NO: 4 wherein a first cysteine is introduced at the position corresponding to the aspartic acid residue at position 383 in SEQ ID NO: 4 and a second cysteine is introduced at the position corresponding to the tyrosine residue at position 349 in SEQ ID NO: 4, and
the hitchhiker subunit comprises an amino acid sequence having at least 60%, 70%, 80%, 90% or 95% identity to SEQ ID NO: 2 wherein cysteine is introduced at the position corresponding to the lysine residue at position 155 in SEQ ID NO: 2.
In one embodiment of a mutant FAD-dependent glucose dehydrogenase,
the catalytic subunit comprises an amino acid sequence having at least 60%, 70%, 80%, 90% or 95% identity to SEQ ID NO: 7 wherein cysteine is introduced at the position corresponding to the proline residue at position 202 in SEQ ID NO: 7,
the electron transfer subunit comprises an amino acid sequence having at least 60%, 70%, 80%, 90% or 95% identity to SEQ ID NO: 8 or amino acids 326 to 420 of SEQ ID NO: 8 wherein a first cysteine is introduced at the position corresponding to the glutamic acid residue at position 375 in SEQ ID NO: 8 and a second cysteine is introduced at the position corresponding to the tyrosine residue at position 341 in SEQ ID NO: 8, and
the hitchhiker subunit comprises an amino acid sequence having at least 60%, 70%, 80%, 90% or 95% identity to SEQ ID NO: 6 wherein cysteine is introduced at the position corresponding to the arginine residue at position 157 in SEQ ID NO: 6.
In one embodiment of a mutant FAD-dependent glucose dehydrogenase,
the catalytic subunit comprises an amino acid sequence having at least 60%, 70%, 80%, 90% or 95% identity to SEQ ID NO: 13 wherein cysteine is introduced at the position corresponding to the proline residue at position 204 in SEQ ID NO: 13,
the electron transfer subunit comprises an amino acid sequence having at least 60%, 70%, 80%, 90% or 95% identity to SEQ ID NO: 14 or amino acids 332 to 481 of SEQ ID NO: 14 wherein a first cysteine is introduced at the position corresponding to the histidine residue at position 382 in SEQ ID NO: 14 and a second cysteine is introduced at the position corresponding to the alanine residue at position 347 in SEQ ID NO: 14, and
the hitchhiker subunit comprises an amino acid sequence having at least 60%, 70%, 80%, 90% or 95% identity to SEQ ID NO: 12 wherein cysteine is introduced at the position corresponding to the alanine residue at position 168 in SEQ ID NO: 12.
In one embodiment of a mutant FAD-dependent glucose dehydrogenase,
the catalytic subunit comprises an amino acid sequence having at least 60%, 70%, 80%, 90% or 95% identity to SEQ ID NO: 17 wherein cysteine is introduced at the position corresponding to the proline residue at position 200 in SEQ ID NO: 17,
the electron transfer subunit comprises an amino acid sequence having at least 60%, 70%, 80%, 90% or 95% identity to SEQ ID NO: 18 or amino acids 340 to 465 of SEQ ID NO: 18 wherein a first cysteine is introduced at the position corresponding to the aspartic acid residue at position 389 in SEQ ID NO: 18 and a second cysteine is introduced at the position corresponding to the tyrosine residue at position 355 in SEQ ID NO: 18, and
the hitchhiker subunit comprises an amino acid sequence having at least 60%, 70%, 80%, 90% or 95% identity to SEQ ID NO: 16 or amino acids 19 to 195 of SEQ ID NO: 16 wherein cysteine is introduced at the position corresponding to the arginine residue at position 182 in SEQ ID NO: 16.
In one embodiment of a mutant FAD-dependent glucose dehydrogenase,
the catalytic subunit comprises an amino acid sequence having at least 60%, 70%, 80%, 90% or 95% identity to SEQ ID NO: 21 wherein cysteine is introduced at the position corresponding to the proline residue at position 204 in SEQ ID NO: 21,
the electron transfer subunit comprises an amino acid sequence having at least 60%, 70%, 80%, 90% or 95% identity to SEQ ID NO: 22 or amino acids 418 to 522 of SEQ ID NO: 22 wherein a first cysteine is introduced at the position corresponding to the serine residue at position 467 in SEQ ID NO: 22 and a second cysteine is introduced at the position corresponding to the tyrosine residue at position 433 in SEQ ID NO: 22, and
the hitchhiker subunit comprises an amino acid sequence having at least 60%, 70%, 80%, 90% or 95% identity to SEQ ID NO: 20 or amino acids 14 to 207 of SEQ ID NO: 20 wherein cysteine is introduced at the position corresponding to the glutamine residue at position 198 in SEQ ID NO: 20.
The mutant GDH according to one embodiment of the present invention can be obtained by genetic engineering. More specifically, the mutant GDH can be obtained by introducing the mutations of interest by site-directed mutagenesis or the like to the gene encoding GDH, and expressing the resulting mutant GDH gene in an arbitrary host cell or cell-free translation system.
The gene encoding the GDH catalytic (a) subunit is not limited as long as it has a nucleotide sequence corresponding to the amino acid sequence of the GDH α subunit. Specific examples of the gene include a DNA composed of nucleotide positions 764 to 2380 of SEQ ID NO:1. The α-subunit gene may be a DNA having the nucleotide sequence composed of nucleotide positions 764 to 2380 of the nucleotide sequence of SEQ ID NO:1, or a DNA which hybridizes, under stringent conditions, with a probe that can be prepared from this sequence, which DNA encodes a protein having the GDH activity.
Specific examples of the gene encoding the GDH electron transfer (β) subunit include a DNA containing the nucleotide sequence composed of nucleotide positions 2386 to 3660 of SEQ ID NO: 1. The β-subunit gene may be a DNA having the nucleotide sequence composed of nucleotide positions 2386 to 3660 of SEQ ID NO: 1, or a DNA which hybridizes, under stringent conditions, with a probe that can be prepared from this sequence, which DNA encodes a protein capable of functioning as the β subunit.
Specific examples of the gene encoding the GDH hitchhiker subunit (γ) subunit include a DNA containing the nucleotide sequence composed of nucleotide positions 258 to 761 of SEQ ID NO:1. The α-subunit gene may be a DNA having the nucleotide sequence composed of nucleotide positions 258 to 761 of SEQ ID NO:1, or a DNA which hybridizes, under stringent conditions, with a probe that can be prepared from this sequence, which DNA encodes a protein capable of functioning as the γ subunit.
Examples of the stringent conditions described above include conditions that allow hybridization of DNAs having an identity of preferably at least 80%, more preferably at least 90%, especially preferably at least 95%, with each other and does not allow hybridization of DNAs having an identity of less than 80%, less than 90% or less than 95%. Specific examples of the stringent conditions include those in which washing is carried out with 0.1×SSC and 0.1% SDS at 60° C., 65° C., or 68° C.
The α-subunit gene, β-subunit gene, and γ-subunit gene can be obtained by, for example, PCR using chromosomal DNA of the Burkholderia cepacia KS1 strain as a template. The PCR primers therefor can be prepared by chemical synthesis based on the above-described nucleotide sequences. Alternatively, the genes can be obtained from chromosomal DNA of the Burkholderia cepacia KS1 strain by hybridization using, as probes, oligonucleotides prepared based on the above-described sequences. Strains other than the KS1 strain, such as the Burkholderia cenocepacia J2315 strain, Burkholderia thailandensis TXDOH strain, Ralstonia pickettii 12D strain, Ralstonia solanacearum IPO1609 strain, and Burkholderia phytofirmans PsJN strain, may also be used.
Each of the GDH α-subunit, β-subunit, and γ-subunit having a desired mutation(s) can be obtained by introducing a nucleotide mutation(s) corresponding to the desired amino acid mutation(s) (such as the substitution with a cysteine residue) to a DNA encoding the GDH subunit by site-directed mutagenesis, and expressing the resulting mutant DNA using an appropriate expression system. Further, by allowing expression from the DNA encoding the mutant GDH α subunit, and also from the DNA encoding the mutant β subunit and the DNA encoding the mutant γ subunit, a mutant GDH can be obtained. The introduction of the mutation(s) to the DNA encoding each subunit may be carried out using a polycistronic DNA fragment encoding the γ subunit, α subunit, and β subunit in this order.
The polycistronic DNA fragment encoding the γ subunit, α subunit, and β subunit in this order can be obtained by, for example, PCR using chromosomal DNA of the Burkholderia cepacia KS1 strain as a template, and oligonucleotides having the nucleotide sequences of SEQ ID NOs:9 and 10 as primers.
The vector used for obtaining the genes of the GDH subunits, introducing the mutations, expressing the genes, and the like include vectors capable of functioning in bacteria belonging to the genus Escherichia, such as pTrc99A, pBR322, pUC18, pUC118, pUC19, pUC119, pACYC184, and pBBR122. Examples of the promoter to be used for the gene expression include lac, trp, tac, trc, PL, tet, and PhoA. By introducing the γ subunit gene, α subunit gene, and β subunit gene to an appropriate site in an expression vector containing a promoter, insertion of the genes into the vector and linking of the promoter can be carried out in the same single process. Examples of such an expression vector include pTrc99A, pBluescript, and pKK223-3.
The γ subunit gene, α subunit gene, and β subunit gene may be incorporated in the chromosomal DNA of the host microorganism in a form which allows the expression. Examples of the method of transformation of the microorganism with the recombinant vector include the competent cell method by calcium treatment, the protoplast method, and the electroporation method.
Examples of the host microorganism include, but are not limited to, bacteria belonging to the genus Bacillus such as Bacillus subtilis; yeasts such as Saccharomyces cerevisiae; and filamentous fungi such as Aspergillus niger. Any host microorganism suitable for production of a foreign protein may be used.
The transformant such as a microorganism transformed with the mutant GDH genes may be cultured by an appropriate culture method depending on the type of the transformant. Examples of the conditions for the culture include culturing at 30 to 37° C. for 12 to 24 hours.
The mutant GDH may be used also after purification. The mutant GDH may contain an additional sequence such as a tag sequence for purification.
The mutant GDH according to one embodiment of the present invention, or the microorganism which expresses the mutant GDH, may be used as a component of an enzyme electrode of a glucose sensor. Specific examples of the glucose sensor include glucose sensors that use, as a working electrode, an enzyme electrode formed by immobilization of the mutant GDH on a surface of an electrode such as a gold electrode, platinum electrode, or carbon electrode. The sensor means a measurement system for electrochemically measuring the concentration of a test substance of interest, and usually contains three electrodes, which are a working electrode (enzyme electrode), counter electrode (platinum or the like), and reference electrode (Ag/AgCl or the like). The sensor may also be a two-electrode system constituted by a working electrode and a counter electrode, such as those used in conventional, simple blood glucose level systems. The sensor preferably further contains: a constant-temperature cell in which a buffer and a test sample are to be placed; a power source for applying a voltage to the working electrode; an ammeter; a recorder; and/or the like. The sensor may be either a batch-type sensor or flow-type sensor. In particular, the flow-type sensor may be a sensor capable of continuous measurement of the blood glucose level. More specifically, the sensor may be a sensor having a two-electrode system or three-electrode system on which the enzyme of the present invention is immobilized, which electrode system is inserted into a blood sample or dialysis sample that is continuously supplied, or into blood or interstitial fluid, to perform the measurement. The structure of such an enzyme sensor is well known in the art, and described in, for example, Biosensors—Fundamental and Applications—Anthony P F. Turner, Isao Karube and George S. Wilson, Oxford University Press 1987.
The sensor according to one mode of the present invention may be a direct electron transfer-type sensor containing no electron-transfer mediator.
The method of immobilizing the enzyme (mutant GDH) on the electrode is not limited. Examples of the method include a method in which enzyme molecules are chemically immobilized on the electrode using a cross-linking agent or the like, a method in which enzyme molecules are indirectly immobilized on the electrode using a binder or the like, and a method by physical adsorption of enzyme molecules to the electrode.
The method in which the enzyme is chemically immobilized on the electrode using a cross-linking agent or the like may be a method in which the enzyme is directly immobilized on the electrode. Alternatively, a method such as the one disclosed in U.S. Ser. No. 10/563,242B2 may be used. More specifically, this method is a method in which a monolayer (SAM)-forming molecule is immobilized on the electrode, and a molecular recognition element containing the enzyme is immobilized through the SAM-forming molecule.
The monolayer-forming molecule is a compound capable of binding to the electrode, and of allowing binding of the enzyme molecule thereto. By binding a plurality of molecules of the compound in the same direction on the electrode surface, a monolayer film can be formed. By using the monolayer-forming molecule, the distance between the electrode and the enzyme molecule can be controlled.
The monolayer-forming molecule preferably contains: a first functional group having affinity to the electrode, a spacer region, and a second functional group reactive with a functional group contained in the enzyme molecule. More preferably, the monolayer-forming molecule has a structure in which the first functional group having affinity to the electrode is bound to a first end of the spacer region, and in which the second functional group reactive with a functional group contained in the enzyme molecule is bound to a second end of the spacer region. Here, examples of the first functional group having affinity to the electrode include a thiol group and dithiol group in cases where the electrode is a metal; and pyrene and porphyrin in cases where the electrode is carbon. On the other hand, examples of the second functional group reactive with a functional group contained in the enzyme molecule include a succinimide group in cases of reaction with an amino group (including a terminal amino group and side-chain amino group) contained in the enzyme molecule; and an oxazoline group in cases of reaction with a carboxyl group (including a terminal carboxyl group and side-chain carboxyl group) contained in the enzyme molecule. Examples of a monolayer-forming molecule containing a thiol group or dithiol group, and succinimide group, include DSH as described later in Examples.
The measurement of the glucose concentration using the glucose sensor of the present invention can be carried out as follows. A buffer is placed in a constant-temperature cell of the sensor, and the temperature of the cell is kept constant. As a working electrode, an enzyme electrode on which the mutant GDH is immobilized is used. As a counter electrode, for example, a platinum electrode is used. As a reference electrode, for example, an Ag/AgCl electrode is used. A constant voltage is applied to the working electrode. After the electric current becomes constant, a sample containing glucose is placed in the constant-temperature cell, and the increase in the electric current is measured. According to a calibration curve prepared using glucose solutions having standard concentrations, the glucose concentration in the sample can be calculated.
The mutant GDH according to one embodiment of the present invention can also be used as a component of a glucose assay kit. The glucose assay kit may contain a coloring or luminescence reagent, a dilution buffer, a standard substance, manufacturer's instructions, and/or the like in addition to the mutant GDH.
For example, a glucose sensor and a glucose assay kit using a wild-type GDH of Burkholderia cepacia are described in US 2004/0023330 A1. The mutant GDH can be applied in the similarly manner.
The present invention is described below more specifically by showing non-limiting Examples.
As a GDH comprising a cytochrome C-containing subunit, a CyGDH derived from B. cepacia was used. The CyGDH derived from B. cepacia is an oligomer enzyme composed of the γ, a, and β subunits. These three subunits are encoded in the gene having the nucleotide sequence of SEQ ID NO:1. Based on this sequence, pTrc99Aγα(QYY)β, which contains a polynucleotide modified such that the encoded α subunit has a QYY mutation, and pTrc99Aγα(QYY)β330-His, which contains a polynucleotide modified such that the α subunit has the QYY mutation, and such that the encoded β subunit is a deletion-type β subunit composed of amino acid positions 330 to 425, were used (US 2019-0010215).
With these vectors, site-directed mutagenesis was carried out such that the following amino acid substitutions were introduced to the subunits. Mutant 1 is a mutant in which position 154 of the γ subunit is substituted with a cysteine; position 345 of the β subunit is substituted with a cysteine; and a disulfide bond is formed between these cysteines. Mutant 2 is a mutant in which position 155 of the γ subunit is substituted with a cysteine; position 349 of the β subunit is substituted with a cysteine; and a disulfide bond is formed between these cysteines. Mutant 3 is a mutant in which position 205 of the α subunit is substituted with a cysteine; position 383 of the β subunit is substituted with a cysteine; and a disulfide bond is formed between these cysteines. Mutant 4 is a mutant in which position 205 of the α subunit is substituted with a cysteine; position 383 of the β subunit is substituted with a cysteine; a disulfide bond (α-β disulfide bond) is formed between these cysteines; position 345 of the β subunit is substituted with a cysteine; position 154 of the γ subunit is substituted with a cysteine; and a disulfide bond (β-γ disulfide bond) is formed between these cysteines. Mutant 5 is a mutant in which position 205 of the α subunit is substituted with a cysteine; position 383 of the β subunit is substituted with a cysteine; a disulfide bond (α-β disulfide bond) is formed between these cysteines; position 349 of the β subunit is substituted with a cysteine; position 155 of the γ subunit is substituted with a cysteine; and a disulfide bond (β-γ disulfide bond) is formed between these cysteines.
E. coli was transformed with each vector obtained, and the resulting transformant was cultured to allow expression of each mutant GDH.
The culture and purification of glucose dehydrogenase were carried out by the method described in US 2019-0010215.
Each mutant GDH was heat-treated at each temperature for 15 minutes, and then the enzyme activity was measured according to the method described in US 2019-0010215 with a system using PMS/DCIP.
The results are shown in
As shown in
Subsequently, the thermal stability was evaluated for Mutants 4 and 5, in which cysteine was introduced not only to the α subunit, but also to the γ subunit, to form the α-β and β-γ disulfide bonds.
As a result, as shown in
Subsequently, the activity was investigated after performing heat treatment at 75° C. for different lengths of time. As a result, Mutants 4 and 5 showed maintenance of the activity even after 60 minutes of the heat treatment. In particular Mutant 5 was found to be an enzyme having high thermal stability with which not less than 60% of the original activity can be maintained even after 60 minutes of the heat treatment.
Subsequently, an enzyme electrode was prepared using Mutant 5, and used for measurement of the glucose concentration.
First, an enzyme electrode was prepared by immobilizing the Mutant, on a gold surface through a monolayer-forming molecule. As the monolayer-forming molecule, DSH, shown below, was used.
Specifically, a gold wire (diameter, 0.5 mm; length, 6 to 7 cm) was immersed in Piranha solution (200 μl) at room temperature for 2 hours, and then washed with acetone. The wire was then immersed in a solution of DSH in acetone (concentration, 20 μM), and incubated at 25° C. for 24 hours to allow binding of the thiol groups of DSH to the gold surface. Subsequently, the wire was washed with acetone, and then immersed in phosphate buffer (300 μl) containing the Mutant GDH (concentration, 0.03 mg/ml), followed by incubation at 4° C. overnight to allow binding of the Mutant GDH through a functional group of DSH, thereby obtaining an enzyme electrode in which the Mutant GDH was immobilized on the surface.
Using the enzyme electrode prepared as described above, the response current value for 0 mM (background), 1 mM, 2 mM, 5 mM, 10 mM, 20 mM, or 50 mM aqueous glucose solution was measured by chronoamperometry. The glucose measurement was carried out at 37° C. using a counter electrode (Pt wire) and a reference electrode (silver/silver chloride) by application of an electric potential of +0.4 V (vs. silver/silver chloride) to the working electrode.
As a result, as shown in
Thus, it was shown that the glucose concentration can be measured with a sensor using a GDH in which cysteines are introduced to bind subunits to each other by disulfide bonding. Further, it was surprisingly found that the introduction of the cysteines led to improvement of the electrode properties.
The enzyme electrode carrying Mutant 5 prepared as described above was immersed in a 20 mM glucose solution at room temperature together with a counter electrode (Pt wire) and a reference electrode (silver/silver chloride). The current response was continuously measured for four weeks by application of an electric potential of +0.2 V (vs. silver/silver chloride) to the working electrode and the results were compared to the enzyme electrode carrying QYY GDH with no introduction of a cysteine residue. As a result, as shown in
Next, the enzyme electrode carrying Mutant 5 was immersed in a glucose solution (0, 1, 3, 5, 10, 15 and 20 mM) at room temperature together with a counter electrode (Pt wire) and a reference electrode (silver/silver chloride). The electric potential of +0.2 V (vs. silver/silver chloride) was continuously applied to the working electrode and the response current was measured over time and plotted and the results were compared to the enzyme electrode carrying QYY GDH with no introduction of a cysteine residue. As a result, as shown in
These data clearly show that the enzyme having introduced cysteine residues has high stability and can be suitably used for a long-term measurement of glucose.
Preparation of Mutant GDH from E. americana and Evaluation of Heat Resistance
As a GDH comprising a cytochrome C-containing subunit, a CyGDH derived from E. americana was used. The CyGDH derived from E. americana is an oligomer enzyme composed of the γ, α, and β subunits. These three subunits are encoded in the gene having the nucleotide sequence of SEQ ID NO:5. The CyGDH gene was inserted into pTrc99A.
With this vector, site-directed mutagenesis was carried out such that the following amino acid substitutions were introduced to the subunits. Mutant E is a mutant in which position 202 of the α subunit is substituted with a cysteine; position 375 of the β subunit is substituted with a cysteine; a disulfide bond (α-β disulfide bond) is formed between these cysteines; position 341 of the β subunit is substituted with a cysteine; position 157 of the γ subunit is substituted with a cysteine; and a disulfide bond (β-γ disulfide bond) is formed between these cysteines.
E. coli was transformed with each vector obtained, and the resulting transformant was cultured to allow expression of the mutant GDH.
The culture and purification of glucose dehydrogenase were carried out by the method described in US 2019-0010215.
The mutant GDH was heat-treated at 65° C., and the enzyme activity was measured according to the method described in US 2019-0010215 with a system using PMS/DCIP and the time-dependent change of the enzyme activity was plotted.
The results are shown in
These data clearly show that the disulfide bond formation is also effective for enhancing stability of oligomeric GDH enzymes of various origin.
Preparation of Mutant GDHs from Silvimonas terrae and Evaluation of Heat Resistance
As a GDH comprising a cytochrome C-containing subunit, a CyGDH derived from Silvimonas terrae was used. The CyGDH derived from Silvimonas terrae is an oligomer enzyme composed of the γ, α, and β subunits. These three subunits are encoded in the gene having the nucleotide sequence of SEQ ID NO: 11. The CyGDH gene was inserted into pTrc99A.
With this vector, site-directed mutagenesis was carried out such that the following amino acid substitutions were introduced to the subunits. Two mutant CyGDHs were prepared: One is a mutant in which proline at position 204 of the α subunit is substituted with a cysteine; histidine at position 382 of the β subunit is substituted with a cysteine; a disulfide bond (α-β disulfide bond) is formed between these cysteines; alanine at position 347 of the β subunit is substituted with a cysteine; alanine at position 168 of the γ subunit is substituted with a cysteine; and a disulfide bond (β-γ disulfide bond) is formed between these cysteines (αP204CβH382C-γA168CβA347C).
The other is a mutant in which proline at position 204 of the α subunit is substituted with a cysteine; histidine at position 382 of the β subunit is substituted with a cysteine; a disulfide bond (α-β disulfide bond) is formed between these cysteines (αP204CβH382C).
E. coli was transformed with each vector obtained, and the resulting transformants were cultured to allow expression of the mutant GDHs.
The culture and purification of glucose dehydrogenase were carried out by the method described in US 2019-0010215.
The mutant GDHs as wells as the wild type GDH were heat-treated at 60° C., and the enzyme activity was measured according to the method described in US 2019-0010215 with a system using Ru/MTT and the time-dependent change of the enzyme activity was plotted.
As shown in
Preparation of Mutant GDHs from Zymobacter palmae and Evaluation of Heat Resistance
As a GDH comprising a cytochrome C-containing subunit, a CyGDH derived from Zymobacter palmae was used. The CyGDH derived from Zymobacter palmae is an oligomer enzyme composed of the γ, α, and β subunits. These three subunits are encoded in the gene having the nucleotide sequence of SEQ ID NO: 15. A modified CyGDH gene in which the nucleotide “g” at position 55 is replaced with “a” such that Val at position 19 in SEQ ID NO: 16 is changed to Met and the γ subunit is translated from this position was inserted into pTrc99A.
With this vector, site-directed mutagenesis was carried out such that the following amino acid substitutions were introduced to the subunits. Two mutant CyGDHs were prepared: One is a mutant in which proline at position 200 of the α subunit is substituted with a cysteine; aspartic acid at position 389 of the β subunit is substituted with a cysteine; a disulfide bond (α-β disulfide bond) is formed between these cysteines; tyrosine at position 355 of the β subunit is substituted with a cysteine; arginine at position 164 of the γ subunit which corresponds to arginine at position 182 in SEQ ID NO: 16 is substituted with a cysteine; and a disulfide bond (β-γ disulfide bond) is formed between these cysteines (αP200CβD389C-γR182CβY355C). The other is a mutant in which proline at position 200 of the α subunit is substituted with a cysteine; aspartic acid at position 389 of the β subunit is substituted with a cysteine; a disulfide bond (α-β disulfide bond) is formed between these cysteines (αP200CβD389C).
E. coli was transformed with each vector obtained, and the resulting transformants were cultured to allow expression of the mutant GDHs.
The culture and purification of glucose dehydrogenase were carried out by the method described in US 2019-0010215.
The mutant GDHs as wells as the wild type GDH were heat-treated at 60° C., and the enzyme activity was measured according to the method described in US 2019-0010215 with a system using Ru/MTT and the time-dependent change of the enzyme activity was plotted.
As shown in
Preparation of Mutant GDHs from Cobetia sp. and Evaluation of Heat Resistance
As a GDH comprising a cytochrome C-containing subunit, a CyGDH derived from Cobetia sp. was used. The CyGDH derived from Cobetia sp. is an oligomer enzyme composed of the γ, α, and β subunits. These three subunits are encoded in the gene having the nucleotide sequence of SEQ ID NO: 19. A CyGDH gene in which the γ subunit (amino acids 14-207 of SEQ ID NO: 20) is translated from the “atg” codon at positions 40-42 in SEQ ID NO: 19 was inserted into pTrc99A.
With this vector, site-directed mutagenesis was carried out such that the following amino acid substitutions were introduced to the subunits. One mutant CyGDH was prepared which is a mutant in which proline at position 204 of the α subunit is substituted with a cysteine; serine at position 467 of the β subunit is substituted with a cysteine; a disulfide bond (α-β disulfide bond) is formed between these cysteines; tyrosine at position 433 of the β subunit is substituted with a cysteine; glutamine at position 185 of the γ subunit which corresponds to glutamine at position 198 in SEQ ID NO: 20 is substituted with a cysteine; and a disulfide bond (β-γ disulfide bond) is formed between these cysteines (αP204CβS467C-γQ198CβY433C).
E. coli was transformed with each vector obtained, and the resulting transformants were cultured to allow expression of the mutant GDHs.
The culture and purification of glucose dehydrogenase were carried out by the method described in US 2019-0010215.
The mutant GDH as wells as the wild type GDH were heat-treated at 60° C., and the enzyme activity was measured according to the method described in US 2019-0010215 with a system using Ru/MTT and the time-dependent change of the enzyme activity was plotted.
As shown in
These data clearly show that the disulfide bond formation is also effective for enhancing stability of oligomeric GDH enzymes of various origin.
The contents of all publications including patents and patent applications as well as non-patent documents cited in the present description are hereby incorporated by reference to the same extent as if all contents were clearly described.
| Number | Date | Country | |
|---|---|---|---|
| Parent | 17215476 | Mar 2021 | US |
| Child | 17507800 | US |
